Preoperative Risk Stratification Approach
Preoperative risk stratification should follow a stepwise approach using validated tools like the Revised Cardiac Risk Index (RCRI) to assess cardiac risk, with further testing based on risk level, functional capacity, and surgery-specific factors. 1
Step 1: Initial Assessment
Urgency evaluation: Determine if surgery is emergent (cannot delay), urgent, time-sensitive, or elective 2, 1
Prior cardiac interventions: Check if patient has undergone coronary revascularization in past 5 years or coronary evaluation in past 2 years 2
Clinical risk factors: Identify major, intermediate, and minor predictors:
Major Predictors Intermediate Predictors Minor Predictors Unstable coronary syndromes Prior MI/pathologic Q waves Advanced age Decompensated heart failure Mild angina pectoris Abnormal ECG Significant arrhythmias Compensated/prior heart failure Non-sinus rhythm Severe valvular disease Diabetes mellitus Low functional capacity Renal insufficiency History of stroke Uncontrolled hypertension
Step 2: Risk Calculation
Validated risk scores:
- Revised Cardiac Risk Index (RCRI)
- American College of Surgeons NSQIP risk calculator
- EuroSCORE (for cardiac surgery)
- Mayo Surgical Risk Score 1
Surgery-specific risk:
- Low risk (<1% cardiac events): Endoscopy, superficial procedures, cataract, breast
- Intermediate risk (1-5% cardiac events): Carotid endarterectomy, head and neck, intraperitoneal, orthopedic
- High risk (>5% cardiac events): Aortic, major vascular, prolonged procedures with large fluid shifts 2
Step 3: Functional Capacity Assessment
- Evaluate using:
- Duke Activity Status Index (DASI)
- Two-flight stairs test
- Poor functional capacity: <4 METs or DASI <34
- Good functional capacity: ≥4 METs or DASI ≥34 1
Step 4: Testing Strategy Based on Risk
Low risk (RCRI 0 points) + good functional capacity:
- Proceed to surgery without further cardiac testing 1
Intermediate risk (RCRI 1-2 points):
High risk (RCRI ≥3 points):
Special populations:
Step 5: Perioperative Management
Beta-blockers:
- Continue in patients already on therapy
- Consider initiating in high-risk patients (≥3 RCRI factors) >1 day before surgery
- Avoid starting on day of surgery (Class III: Harm) 1
Statins:
- Continue in patients already taking them
- Consider initiating for vascular surgery or elevated-risk procedures 1
Antiplatelet therapy:
- Continue dual antiplatelet therapy for urgent surgery within 4-6 weeks of stent placement
- Avoid elective surgery within 30 days of BMS or 12 months of DES if DAPT must be discontinued 1
Common Pitfalls to Avoid
- Ordering routine tests without clinical indication
- Starting beta-blockers on day of surgery (increases stroke and mortality risk)
- Performing elective surgery too soon after coronary stent placement
- Overlooking poor functional capacity as a significant risk factor
- Failing to use validated risk prediction tools 1, 3
By following this structured approach to preoperative risk stratification, clinicians can identify patients at increased risk for perioperative cardiovascular complications and implement appropriate risk-reduction strategies to improve outcomes.